Anne Wojcicki, co-founder and former CEO of 23andMe, will regain control of the embattled genetic testing company through a ...

San Francisco-based 23andMe filed for Chapter 11 bankruptcy protection in the Eastern Missouri federal court district in ...

Since filing for bankruptcy, 23andMe officials said that they have received 1.9 million requests from customers to delete their genetic data.

On Monday, Senate Republicans proposed major revisions of the House’s giant tax-and-spending bill. The Senate’s plan creates ...

Anne Wojcicki, co-founder and former CEO of 23andMe, has bid to buy back the genetic testing platform, which was pronounced ...

The Nasdaq Composite lost 0.5%. Kroger shares led the S&P 500. 23andMe said late Friday that TTAM Research Institute, Wojcicki’s nonprofit, was offering $305 million for the company’s assets. Last ...

The soybean market is 1 to 2 cents lower at midday on Friday. July beans hit the highest price since mid-May early this ...

DNA firm is back under old management, Meta is poaching AI talent, TikTok's deadline looms, Kraft goes natural with dyes, and ...

The American Diabetes Association’s annual conference kicks off amid a dynamic year for diabetes tech, as access improves for ...

AstraZeneca signed a potential $5 billion research deal with Chinese drugmaker CSPC. Eli Lilly is buying Verve Therapeutics for $1 billion upfront plus a CVR potentially worth another $300 million.